Roland Krämer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roland Krämer has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Hans Pritzkow
University of Heidelberg, Im Neuenheimer Feld 275,Heidelberg,Germany
9 shared publications- Igor Olegovich Fritsky
Taras Shevchenko National University of Kyiv
7 shared publications Helga Szelke
Anorganisch-Chemisches Institut, Universität Heidelberg, Im Neuenheimer Feld 270, Germany
4 shared publicationsNora Graf
Anorganisch-Chemisches Institut, Ruprecht-Karls-Universität Heidelberg, 69120 Heidelberg, Germany
4 shared publications- Andriy Mokhir
Friedrich-Alexander-University of Erlangen-Nürnberg (FAU), Department of Chemistry and Pharmacy, Organic Chemistry II, 91058 Erlangen, Germany
3 shared publications - Job Harenberg
Ruprecht-Karls-Universität Heidelberg
3 shared publications
Latest Publications
- 1 June 2019
- Published by Elsevier in Process Biochemistry
- Vol. 81, 182-187
Phenomenological investigation of the cytotoxic activity of fucoidan isolated from Fucus vesiculosus
- 1 June 2019
- Published by Elsevier in Process Biochemistry
- Vol. 81, 182-187
Phenomenological investigation of the cytotoxic activity of fucoidan isolated from Fucus vesiculosus
- 1 October 2017
- Published by Elsevier in Dyes and Pigments
- Vol. 145, 80-94
Polyamine-modified near-infrared cyanine dyes for targeting the nuclei and nucleoli of cells
- 1 October 2017
- Published by Elsevier in Dyes and Pigments
- Vol. 145, 80-94
Polyamine-modified near-infrared cyanine dyes for targeting the nuclei and nucleoli of cells
- 28 April 2016
- Published by Springer Nature
- p. 259-417
Encapsulation by Coordination Capsules
- 22 February 2016
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 12 (4) , 1114-1117
Zinc( ii )-induced control of the internalization of a near-infrared fluorescent probe by live cells
We describe zinc-promoted cellular uptake of a near-infrared fluorophore modified with a terpyridine ligand. In response to varying concentrations of exogenous zinc(ii), we observed increasing cellular uptake in live HeLa cells as well as other cell lines, whereas only negligible staining was detected in the absence of zinc(ii).
- 22 February 2016
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 12 (4) , 1114-1117
Zinc( ii )-induced control of the internalization of a near-infrared fluorescent probe by live cells
We describe zinc-promoted cellular uptake of a near-infrared fluorophore modified with a terpyridine ligand. In response to varying concentrations of exogenous zinc(ii), we observed increasing cellular uptake in live HeLa cells as well as other cell lines, whereas only negligible staining was detected in the absence of zinc(ii).
- Open Access
- 20 March 2015
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 51 (34) , 7360-7363
A polyamine-modified near-infrared fluorescent probe for selective staining of live cancer cells
A novel polyamine-modified near-infrared fluorescent probe has been developed that allows for selective labeling of living cancer cells in presence of non-cancer cells.
- 20 March 2015
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 51 (34) , 7360-7363
Open AccessA polyamine-modified near-infrared fluorescent probe for selective staining of live cancer cells
A novel polyamine-modified near-infrared fluorescent probe has been developed that allows for selective labeling of living cancer cells in presence of non-cancer cells.
- 17 May 2013
- Published by Wiley in Zeitschrift für anorganische und allgemeine Chemie
- Vol. 639 (8-9) , 1636-1639
Monitoring Cu2+‐Binding to a DNA‐Clip‐phen Conjugate and Metal‐centered Redox Processes by a Fluorescent Reporter Group
- 17 May 2013
- Published by Wiley in Zeitschrift für anorganische und allgemeine Chemie
- Vol. 639 (8-9) , 1636-1639
Monitoring Cu2+‐Binding to a DNA‐Clip‐phen Conjugate and Metal‐centered Redox Processes by a Fluorescent Reporter Group
- Open Access
- 1 January 2013
- Published by Springer Nature in Thrombosis Journal
- Vol. 11 (1) , 15
Concept of a point of care test to detect new oral anticoagulants in urine samples
New oral anticoagulants (NOAC) are approved for several indications for prophylaxis and treatment of venous thromboembolism and for prevention of embolism in atrial fibrillation at fixed daily doses without need of laboratory guided dose adjustment. Due to their low molecular weight of about 500 to 600 Dalton and their hydrophilicity free anticoagulant is excreted immediately through glomerular filtration into the urine. Impairment of renal function may increase the plasma concentration of the anticoagulants and lowered creatinine clearance is a declared contraindication. In contrast to the initial aim of development the anticoagulant effect is required to be determined in special clinical situations. Several specific and non-specific assays using plasma samples are currently undergoing standardization. As all NOACs are excreted into the urine, specific assays were developed for this matrix to determine them quantitatively of qualitatively. Urine samples can be easily and repetitively obtained avoiding problems and risks associated with blood sampling. The qualitative assay can be performed as a point of care test (POC) also by the patient by judging the different colours for the absence or presence of the drugs with the naked eye. The test is rapid (results available within 15 min), sensitive, specific and accurate and does not require a purified NOAC as control. The tests may be a tool for clinicians who need to know for treatment decisions if a NOAC is on board or not. As the tests are specific for oral direct thrombin inhibitors and for oral direct factor Xa inhibitors, the indication does not interfere with other qualitative POC test in development using clotting systems. The test may be indicated for patients at acute hospitalization, before surgery or central nervous system puncture anaesthesia, if fibrinolytic therapy is indicated, acute deterioration of renal function, and for control of adherence to therapy.
- 1 January 2013
- Published by Springer Nature in Thrombosis Journal
- Vol. 11 (1) , 15
Open AccessConcept of a point of care test to detect new oral anticoagulants in urine samples
New oral anticoagulants (NOAC) are approved for several indications for prophylaxis and treatment of venous thromboembolism and for prevention of embolism in atrial fibrillation at fixed daily doses without need of laboratory guided dose adjustment. Due to their low molecular weight of about 500 to 600 Dalton and their hydrophilicity free anticoagulant is excreted immediately through glomerular filtration into the urine. Impairment of renal function may increase the plasma concentration of the anticoagulants and lowered creatinine clearance is a declared contraindication. In contrast to the initial aim of development the anticoagulant effect is required to be determined in special clinical situations. Several specific and non-specific assays using plasma samples are currently undergoing standardization. As all NOACs are excreted into the urine, specific assays were developed for this matrix to determine them quantitatively of qualitatively. Urine samples can be easily and repetitively obtained avoiding problems and risks associated with blood sampling. The qualitative assay can be performed as a point of care test (POC) also by the patient by judging the different colours for the absence or presence of the drugs with the naked eye. The test is rapid (results available within 15 min), sensitive, specific and accurate and does not require a purified NOAC as control. The tests may be a tool for clinicians who need to know for treatment decisions if a NOAC is on board or not. As the tests are specific for oral direct thrombin inhibitors and for oral direct factor Xa inhibitors, the indication does not interfere with other qualitative POC test in development using clotting systems. The test may be indicated for patients at acute hospitalization, before surgery or central nervous system puncture anaesthesia, if fibrinolytic therapy is indicated, acute deterioration of renal function, and for control of adherence to therapy.
- 30 September 2011
- Published by Springer Nature
- Vol. 10, 319-340
Metal Complex Derivatives of Peptide Nucleic Acids (PNA)
Peptide nucleic acid (PNA) is a non-cyclic pseudopeptide-nucleic acid structural mimic with promising applications within diagnostics and drug discovery. This review focuses on metal complex derivatives of PNA. Metal ions and their complexes display unique physical and chemical properties and offer the opportunity to introduce new labels and probes for bioanalytical and diagnostic applications of PNA, but also to modulate or to introduce new (for example catalytic) functions and biological activities.
- 30 September 2011
- Published by Springer Nature
- Vol. 10, 319-340
Metal Complex Derivatives of Peptide Nucleic Acids (PNA)
Peptide nucleic acid (PNA) is a non-cyclic pseudopeptide-nucleic acid structural mimic with promising applications within diagnostics and drug discovery. This review focuses on metal complex derivatives of PNA. Metal ions and their complexes display unique physical and chemical properties and offer the opportunity to introduce new labels and probes for bioanalytical and diagnostic applications of PNA, but also to modulate or to introduce new (for example catalytic) functions and biological activities.
- 1 November 2010
- Published by Elsevier in Tetrahedron
- Vol. 66 (45) , 8772-8777
New reaction of 1H-pyrazoles with selenium dioxide: one-pot synthesis of bis(1H-pyrazol-4-yl)selenides
- 1 November 2010
- Published by Elsevier in Tetrahedron
- Vol. 66 (45) , 8772-8777
New reaction of 1H-pyrazoles with selenium dioxide: one-pot synthesis of bis(1H-pyrazol-4-yl)selenides
- 2 March 2010
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 8 (10) , 2327-2331
Pattern-based sensing of sulfated glycosaminoglycans with a dynamic mixture of iron complexes
A dynamic mixture of iron complexes was used as a colorimetric sensor for sulfated glycosaminoglycans. The sensing ensemble was prepared by mixing [FeCl2(H2O)4] with dipicolylamine, the functionalized bipyridyl ligand N-(6-aminohexyl)-4′-methyl-2,2′-bipyridine-4-carboxamide, and the dye Evans Blue. Upon addition of the analytes, characteristic changes in the UV-Vis spectrum of the solutions were observed. The spectral changes allowed identifying different sulfated glucosaminoglycans (unfractionated heparin, low molecular weight heparin, dextran sulfate, chondroitin sulfate A, dermatan sulfate, heparan sulfate) with the help of a linear discriminant analysis. Furthermore, it was possible to distinguish mixtures of unfractionated heparin and heparan sulfate with good resolution.
- 2 March 2010
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 8 (10) , 2327-2331
Pattern-based sensing of sulfated glycosaminoglycans with a dynamic mixture of iron complexes
A dynamic mixture of iron complexes was used as a colorimetric sensor for sulfated glycosaminoglycans. The sensing ensemble was prepared by mixing [FeCl2(H2O)4] with dipicolylamine, the functionalized bipyridyl ligand N-(6-aminohexyl)-4′-methyl-2,2′-bipyridine-4-carboxamide, and the dye Evans Blue. Upon addition of the analytes, characteristic changes in the UV-Vis spectrum of the solutions were observed. The spectral changes allowed identifying different sulfated glucosaminoglycans (unfractionated heparin, low molecular weight heparin, dextran sulfate, chondroitin sulfate A, dermatan sulfate, heparan sulfate) with the help of a linear discriminant analysis. Furthermore, it was possible to distinguish mixtures of unfractionated heparin and heparan sulfate with good resolution.